PT2882753T - Processo para a preparação de pemetrexed e sal de lisina do mesmo - Google Patents
Processo para a preparação de pemetrexed e sal de lisina do mesmo Download PDFInfo
- Publication number
- PT2882753T PT2882753T PT137771440T PT13777144T PT2882753T PT 2882753 T PT2882753 T PT 2882753T PT 137771440 T PT137771440 T PT 137771440T PT 13777144 T PT13777144 T PT 13777144T PT 2882753 T PT2882753 T PT 2882753T
- Authority
- PT
- Portugal
- Prior art keywords
- pemetrexed
- salt
- lysine
- acid
- water
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000398A ITRM20120398A1 (it) | 2012-08-08 | 2012-08-08 | Procedimento di sintesi pemetrexed e suo sale di lisina. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2882753T true PT2882753T (pt) | 2016-12-27 |
Family
ID=47018368
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT137771440T PT2882753T (pt) | 2012-08-08 | 2013-08-08 | Processo para a preparação de pemetrexed e sal de lisina do mesmo |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP2882753B1 (enExample) |
| KR (1) | KR102288417B1 (enExample) |
| CN (1) | CN104736540B (enExample) |
| AU (1) | AU2013301156B2 (enExample) |
| BR (1) | BR112015002429A8 (enExample) |
| CY (1) | CY1118514T1 (enExample) |
| DK (1) | DK2882753T3 (enExample) |
| ES (1) | ES2607890T3 (enExample) |
| HR (1) | HRP20170011T1 (enExample) |
| HU (1) | HUE032304T2 (enExample) |
| IN (1) | IN2015DN00833A (enExample) |
| IT (1) | ITRM20120398A1 (enExample) |
| LT (1) | LT2882753T (enExample) |
| MX (1) | MX362858B (enExample) |
| PL (1) | PL2882753T3 (enExample) |
| PT (1) | PT2882753T (enExample) |
| RS (1) | RS55515B1 (enExample) |
| RU (1) | RU2609006C2 (enExample) |
| SI (1) | SI2882753T1 (enExample) |
| SM (2) | SMT201600474T1 (enExample) |
| TW (1) | TWI609017B (enExample) |
| WO (1) | WO2014024164A1 (enExample) |
| ZA (1) | ZA201501549B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107641124A (zh) * | 2016-07-22 | 2018-01-30 | 上海创诺制药有限公司 | 一种培美曲塞二酸新晶型及其制备方法 |
| CN109836425B (zh) * | 2017-11-24 | 2023-01-24 | 江苏创诺制药有限公司 | 一种合成培美酸的制备工艺 |
| EP3749317A4 (en) | 2018-02-07 | 2022-06-22 | L.E.A.F Holdings Group LLC | PEMETREXED ALPHA-POLYGLUTAMATE AND ASSOCIATED USES |
| US12246018B2 (en) | 2018-02-07 | 2025-03-11 | L.E.A.F. Holdings Group Llc | Gamma polyglutamated pemetrexed and uses thereof |
| CN110128427A (zh) * | 2018-02-09 | 2019-08-16 | 鲁南制药集团股份有限公司 | 培美曲塞缬氨酸盐 |
| CN110128426B (zh) * | 2018-02-09 | 2021-12-14 | 鲁南制药集团股份有限公司 | 培美曲塞谷氨酸盐 |
| CN110128428A (zh) * | 2018-02-09 | 2019-08-16 | 鲁南制药集团股份有限公司 | 培美曲塞丙氨酸盐 |
| CN111333658A (zh) * | 2020-05-06 | 2020-06-26 | 贵州联科中贝制药科技有限公司 | 一种培美曲塞二钠水合物的制备方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0440795B1 (en) | 1988-10-31 | 1994-10-19 | MITSUI TOATSU CHEMICALS, Inc. | Process for preparing organic group-substituted sodium aluminum hydride |
| KR0162654B1 (ko) | 1989-12-11 | 1998-11-16 | 알렌 제이. 시니스갤리 | N-(피롤로[2,3-d]피리미딘-3-일아크릴)-글루타민산 유도체 |
| IL96531A (en) | 1989-12-11 | 1995-08-31 | Univ Princeton | History of Acid N- (Diomeric-H1-Pyrolo] D-2,3 [Pyrimidine-3-Ilacyl (-glutamic, preparation and pharmaceutical preparations containing them) |
| CZ283281B6 (cs) * | 1992-09-25 | 1998-02-18 | Eli Lilly And Company | Způsob přípravy v poloze 5 substituovaných pyrrolo(2,3-d)pyrimidinů |
| US5416211A (en) | 1992-09-25 | 1995-05-16 | Eli Lilly And Company | Process for preparing 5-substituted pyrrolo-[2,3-d]pyrimidines |
| DE19725647A1 (de) | 1997-06-18 | 1998-12-24 | Basf Ag | Cyclopenta[I]phenanthren-Metallkomplex-Katalysatorsysteme |
| ZA987550B (en) | 1997-09-26 | 2000-02-21 | Lilly Co Eli | Processes and intermediates useful to make antifolates. |
| IL150480A0 (en) | 2000-02-25 | 2002-12-01 | Lilly Co Eli | A NOVEL-CRYSTALLINE FORM OF N-[4-[2-(2-AMINO-4, 7-DIHYDRO-4-OXO-3H-PYRROLO[2, 3-d]PYRIMIDIN-5-YL)ETHYL]BENZOYL]-L-GLUTAMIC ACID AND PROCESS THEREFOR |
| JP2008543973A (ja) | 2006-08-14 | 2008-12-04 | シコール インコーポレイティド | ペメトレキセドの中間体の調製方法 |
| JP2008543975A (ja) * | 2006-08-14 | 2008-12-04 | シコール インコーポレイティド | 高度に純粋なペメトレキセド二酸およびその調製方法 |
| CN101591247B (zh) * | 2008-05-30 | 2012-09-05 | 上海希迪制药有限公司 | 合成4-(4-甲酯基苯基)丁醛的方法 |
| IT1401677B1 (it) * | 2010-07-22 | 2013-08-02 | Chemi Spa | Nuovo processo per la sintesi di pemetrexed sale disodico |
| US9655898B2 (en) | 2010-07-28 | 2017-05-23 | Eagle Pharmaceuticals, Inc. | Pharmaceutical compositions containing pemetrexed having extended storage stability |
| WO2012056285A1 (en) * | 2010-10-25 | 2012-05-03 | Fresenius Kabi Oncology Ltd. | An improved process for the preparation of pemetrexed |
-
2012
- 2012-08-08 IT IT000398A patent/ITRM20120398A1/it unknown
-
2013
- 2013-08-06 TW TW102128058A patent/TWI609017B/zh active
- 2013-08-08 IN IN833DEN2015 patent/IN2015DN00833A/en unknown
- 2013-08-08 LT LTEP13777144.0T patent/LT2882753T/lt unknown
- 2013-08-08 MX MX2015001712A patent/MX362858B/es active IP Right Grant
- 2013-08-08 BR BR112015002429A patent/BR112015002429A8/pt not_active Application Discontinuation
- 2013-08-08 SM SM20160474T patent/SMT201600474T1/it unknown
- 2013-08-08 CN CN201380041935.8A patent/CN104736540B/zh active Active
- 2013-08-08 PL PL13777144T patent/PL2882753T3/pl unknown
- 2013-08-08 RS RS20161202A patent/RS55515B1/sr unknown
- 2013-08-08 DK DK13777144.0T patent/DK2882753T3/en active
- 2013-08-08 WO PCT/IB2013/056497 patent/WO2014024164A1/en not_active Ceased
- 2013-08-08 ES ES13777144.0T patent/ES2607890T3/es active Active
- 2013-08-08 HR HRP20170011TT patent/HRP20170011T1/hr unknown
- 2013-08-08 SI SI201330427A patent/SI2882753T1/sl unknown
- 2013-08-08 RU RU2015108042A patent/RU2609006C2/ru active
- 2013-08-08 PT PT137771440T patent/PT2882753T/pt unknown
- 2013-08-08 EP EP13777144.0A patent/EP2882753B1/en active Active
- 2013-08-08 KR KR1020157005932A patent/KR102288417B1/ko active Active
- 2013-08-08 AU AU2013301156A patent/AU2013301156B2/en active Active
- 2013-08-08 HU HUE13777144A patent/HUE032304T2/en unknown
-
2015
- 2015-03-06 ZA ZA2015/01549A patent/ZA201501549B/en unknown
-
2016
- 2016-12-28 SM SM201600474T patent/SMT201600474B/it unknown
- 2016-12-28 CY CY20161101351T patent/CY1118514T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SI2882753T1 (sl) | 2017-02-28 |
| BR112015002429A2 (pt) | 2017-07-04 |
| CN104736540A (zh) | 2015-06-24 |
| IN2015DN00833A (enExample) | 2015-06-12 |
| HK1209426A1 (en) | 2016-04-01 |
| ES2607890T3 (es) | 2017-04-04 |
| EP2882753A1 (en) | 2015-06-17 |
| PL2882753T3 (pl) | 2017-04-28 |
| AU2013301156B2 (en) | 2017-08-31 |
| SMT201600474T1 (it) | 2017-03-08 |
| WO2014024164A1 (en) | 2014-02-13 |
| RS55515B1 (sr) | 2017-05-31 |
| MX362858B (es) | 2019-02-20 |
| EP2882753B1 (en) | 2016-10-05 |
| HUE032304T2 (en) | 2017-09-28 |
| RU2015108042A (ru) | 2016-09-27 |
| BR112015002429A8 (pt) | 2019-07-30 |
| TW201412741A (zh) | 2014-04-01 |
| KR102288417B1 (ko) | 2021-08-11 |
| LT2882753T (lt) | 2016-12-12 |
| TWI609017B (zh) | 2017-12-21 |
| KR20150045458A (ko) | 2015-04-28 |
| CN104736540B (zh) | 2017-08-25 |
| SMT201600474B (it) | 2017-03-08 |
| DK2882753T3 (en) | 2017-01-16 |
| HRP20170011T1 (hr) | 2017-03-10 |
| MX2015001712A (es) | 2015-08-14 |
| CY1118514T1 (el) | 2017-07-12 |
| ITRM20120398A1 (it) | 2014-02-09 |
| ZA201501549B (en) | 2016-01-27 |
| RU2609006C2 (ru) | 2017-01-30 |
| AU2013301156A1 (en) | 2015-02-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104736540B (zh) | 培美曲塞及其赖氨酸盐的制备方法 | |
| ES2730942T3 (es) | Derivados de triazolopiridina como moduladores de la actividad de TNF | |
| US9073899B2 (en) | Solid forms of dabigatran etexilate mesylate and processes for their preparation | |
| ES2554360T3 (es) | Bencenosulfonato de 2-[[[2-[(hidroxiacetil)amino]-4-piridinil]metil]tio]-n-[4 (trifluorometoxi)fenil]-3-piridincarboxamida, cristales del mismo, polimorfos del mismo y procesos para la producción del mismo | |
| ES2608359T3 (es) | Compuestos de pirazolo[3,4-d]pirimidina sustituidos, su preparación y uso como ligandos de receptores sigma | |
| BR112014018763B1 (pt) | Sais de adição de ácido cristalino de um derivado tricíclico ou hidratos dos mesmos e método de produção dos mesmos | |
| EP3679016B1 (en) | Solid forms of 2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)-n-benzylacetamide | |
| CA3221067A1 (en) | A crystalline potassium salt of 1-ethyl- n -((1,2,3,5,6,7-hexahydro- s -indacen-4-yl)carbamoyl)piperidine-4 -sulfonamide | |
| EP2909169B1 (en) | Crystalline phase of (3s,3s') 4,4'-disulfanediylbis(3-aminobutane 1-sulfonic acid) with l-lysine | |
| CN110627793B (zh) | 一种喷昔洛韦与3,5-二羟基苯甲酸共晶及其制备方法 | |
| JP2676113B2 (ja) | 安定な結晶性の塩およびそれを含有するトロンボキサン受容体拮抗剤 | |
| US11814382B2 (en) | Crystal form as ASK1 inhibitor and preparation method and application thereof | |
| JPH0714910B2 (ja) | 安定な結晶性の塩およびそれを含有するトロンボキサン受容体拮抗剤 | |
| HK1209426B (en) | Process for the preparation of pemetrexed and lysin salt thereof | |
| KR20130033242A (ko) | 클로피도그렐의 공결정 | |
| HK40102141A (en) | A crystalline potassium salt of 1-ethyl- n -((1,2,3,5,6,7-hexahydro- s -indacen-4-yl)carbamoyl)piperidine-4 -sulfonamide | |
| RU2802964C2 (ru) | Твердые формы 2-(5-(4-(2-морфолиноэтокси)фенил)пиридин-2-ил)-n-бензилацетамида | |
| HK40086425A (en) | Preparation methods and use of colchicine derivatives | |
| KR900003456B1 (ko) | 4-(1-피롤리디닐)-1-(2,4,6-트리메톡시페닐)-1-부타논 3-하이드록시-5-(하이드록시메틸)-2-메틸이소니코틴알데하이드-5-포스페이트의 제조방법 | |
| WO2013010502A1 (zh) | 一种普拉格雷的酸加成盐及其制备方法和用途 | |
| HK1212321B (en) | Crystalline phase of (3s.3s') 4,4'-disulfanediylbis(3-aminobutane 1 -sulfonic acid) with l-lysine |